ad image

IssueQ22020

1 / 3
Rethinking Pharma’s Responsibilities in a Time of Crisis
COVID-19

Rethinking Pharma’s Responsibilities in a Time of Crisis

Tim Tyson

TriRx Pharmaceutical Services

PAP-Q2-20-CL-001Jul 01, 2020
Drug Approval Trends: Significant Acceleration in Recent Years
Nice Insight Overview

Drug Approval Trends: Significant Acceleration in Recent Years

Nigel Walker

Nice Insight

PAP-Q2-20-NI-001Jul 01, 2020
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
Industry Leader Insight

Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site

Magnus Schroeder, Ph.D.

Avid Bioservices

PAP-Q2-20-CL-002Jul 01, 2020
Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers
Chronokines

Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers

Emilie Branch; Frank D. Lee

Pharma's Almanac

PAP-Q2-20-CL-003Jul 01, 2020
The Essentiality of Transportation to the Pharma Industry
Secure Validated Shipping

The Essentiality of Transportation to the Pharma Industry

Andrew Boyle

Boyle Transportation

PAP-Q2-20-CL-004Jul 01, 2020
Avara Liscate: High Standards and Expertise in Sterile Manufacturing
Fill-Finish Services

Avara Liscate: High Standards and Expertise in Sterile Manufacturing

Andrea Baiocchi

Avara Pharmaceutical Services

PAP-Q2-20-CL-005Jul 01, 2020
Positioning a CDMO to Meet Future Needs
CDMO

Positioning a CDMO to Meet Future Needs

Tyler Kerr; James Balog; Andrew Waaso

Albemarle Fine Chemistry Services

PAP-Q2-20-CL-006Jul 01, 2020
Common Challenges and Solutions of Equipment Ownership and Use
Equipment

Common Challenges and Solutions of Equipment Ownership and Use

Matt Hicks

Federal Equipment Company

PAP-Q2-20-CL-007Jul 01, 2020
Selecting a Microbiome CDMO Partner for the Long Term
Microbiome

Selecting a Microbiome CDMO Partner for the Long Term

Dave Stevens; Jason Rahal

Arranta Bio

PAP-Q2-20-CL-008Jul 01, 2020
Creating Value through Best Practices Across a Global, Integrated Service Provider
Integration

Creating Value through Best Practices Across a Global, Integrated Service Provider

Jeffrey Butler, Ph.D.

AMPAC Fine Chemicals

PAP-Q2-20-CL-009Jul 01, 2020
Leveraging Innovative Technologies to Access Better Data More Efficiently and Cost-Effectively
Research Innovation

Leveraging Innovative Technologies to Access Better Data More Efficiently and Cost-Effectively

Lorraine Rusch, Ph.D.; J. Fred Pritchard, Ph.D.

Celerion

PAP-Q2-20-CL-010Jul 01, 2020
Molecules that Changed Medicine
Molecules

Molecules that Changed Medicine

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q2-20-NI-002Jul 01, 2020
Aseptic Manufacturing with State-of-the-Art Technologies
Aseptic Manufacturing

Aseptic Manufacturing with State-of-the-Art Technologies

Kurt R. Nielsen, Ph.D.

Pii

PAP-Q2-20-CL-011Jul 01, 2020
Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life
Antibody–Drug Conjugates

Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life

Loretta Itri, M.D., F.A.C.P.,; Usama Malik

Immunomedics

PAP-Q2-20-CL-012Jul 01, 2020
Solving Unmet Clinical Needs by Harnessing the Science of Aging
Chronokines

Solving Unmet Clinical Needs by Harnessing the Science of Aging

Emilie Branch; Elizabeth Jeffords

Pharma's Almanac

PAP-Q2-20-CL-013Jul 01, 2020
Computational Discoveries for Clinical Development of Novel Cancer Therapies
Cancer Therapies

Computational Discoveries for Clinical Development of Novel Cancer Therapies

David Alvaro, Ph.D.; Anat Cohen-Dayag, Ph.D.

Pharma's Almanac

PAP-Q2-20-CL-014Jul 01, 2020
Redesigning Organisms as Metabolism Architects
Biosynthesis

Redesigning Organisms as Metabolism Architects

Cyrille Pauthenier, Ph.D.; Filippo Giancarlo Martinelli, PDEng

Abolis

PAP-Q2-20-CL-015Jul 01, 2020
A Therapeutic Strategy for Neurological Disorders
Drug Repositioning

A Therapeutic Strategy for Neurological Disorders

Franck Mouthon; Mathieu Charvériat, Ph.D.

Theranexus

PAP-Q2-20-CL-016Jul 01, 2020
Leveraging the Native Immune Response to Fight Cancer
Immunotherapy

Leveraging the Native Immune Response to Fight Cancer

Asher Nathan

NeoTX

PAP-Q2-20-CL-017Jul 01, 2020
Applying the Principles of Immunotherapy to Infectious Diseases
Immunotherapy

Applying the Principles of Immunotherapy to Infectious Diseases

Jeffrey Stein, Ph.D.

Cidara Therapeutics

PAP-Q2-20-CL-018Jul 01, 2020
1 / 3